Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-08-11Clinical Trial Update: Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC [Phase 2]
Phase 2 study results for the combination of ramucirumab and atezolizumab in non-small cell lung cancer after progression on prior immune ch…
-
CLINICAL_TRIALS trial_result · 2022-08-11Clinical Trial Update: Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating the combination of cetuximab with afatinib in patients with EGFR-mutated non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases [Phase 2]
Phase 2 trial update evaluating pembrolizumab with ferumoxytol-enhanced MRI in patients with non-small cell lung cancer and brain metastases…
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor [Phase 1, Phase 2]
A safety, tolerability, PK and preliminary activity study of GB263T in advanced NSCLC and other solid tumors is in Phase 1/Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: Efficacy and Safety of Furmonertinib in EGFR-Mutant, PD-L1+ Patients With Locally Advanced or Metastatic NSCLC (FUTURE) [Phase 2]
Phase 2 clinical trial update evaluating furmonertinib in EGFR-mutant, PD-L1 positive locally advanced or metastatic non-small cell lung can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluated eribulin mesylate in combination with pemetrexed versus pemetrexed alone as second-line therapy in stage IIIB/IV…
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: Study of HA121-28 in Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update for HA121-28 in patients with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial investigating anlotinib combined with penpulimab and SBRT in metastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating naloxegol for treating stage IIIB/IV non-small cell lung cancer has been terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-01Clinical Trial Update: A Study of XZP-3621 in Chinese Patients With ALK Positive NSCLC [Phase 2]
Phase 2 study of XZP-3621 in ALK-positive non-small cell lung cancer is ongoing with no results yet available.
-
CLINICAL_TRIALS trial_result · 2022-07-28Clinical Trial Update: Bintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating bintrafusp alfa before surgery for untreated resectable non-small cell lung cancer was terminated; results…
-
CLINICAL_TRIALS trial_result · 2022-07-28Clinical Trial Update: Lazertinib/Pemetrexed/Carboplatin After Osimertinib Failure in NSCLC With Brain Metastases [Phase 2]
Phase 2 trial updating efficacy of lazertinib with pemetrexed and carboplatin after osimertinib failure in non-small cell lung cancer with b…
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: The Canada Lymph Node Score Project: A Crossover Trial [Phase 3]
A Phase 3 crossover trial involving the Canada Lymph Node Score Project for lung cancer, completed.
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating oleclumab (MEDI9447) in combination therapy for EGFR-mutant non-small cell lung cancer; the study is a…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Correlation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via ddPCR in NSCLC [Phase 2]
Phase 2 clinical trial examining correlation between efficacy of osimertinib and EGFR T790M status using ddPCR in non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A clinical trial update for FWD1509 in adults with non-small cell lung cancer (Phase 1/2) has been listed, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer [Phase 3]
A Phase 3 clinical trial evaluating NOV-002 in combination with chemotherapy for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: Camrelizumab Combination With SBRT and Concurrent Chemotherapy Treated Stage IV Oligometastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial exploring camrelizumab with SBRT and concurrent chemotherapy for stage IV oligometastatic non-small cell lung cancer, status c…
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: F16IL2 in Combination With Nivolumab in Patients With Non-small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial update for F16IL2 combined with nivolumab in non-small cell lung cancer across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-07-20Clinical Trial Update: Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 Inhibitors [Phase 2]
Phase 2 trial evaluating anlotinib plus penpulimab in advanced non-small cell lung cancer after prior PD-1/PD-L1 inhibitor treatment.
-
CLINICAL_TRIALS trial_result · 2022-07-20Clinical Trial Update: First-line Replacement Maintenance of Envafolimab in Advanced NSCLC [Phase 2]
A Phase 2 trial evaluating first-line replacement maintenance with Envafolimab in advanced non-small cell lung cancer (NSCLC) is ongoing, wi…
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation [Phase 2]
Phase 2 trial evaluating sintilimab with anlotinib for perioperative non-small cell lung cancer guided by minimal residual disease assessmen…
-
CLINICAL_TRIALS trial_result · 2022-07-13Clinical Trial Update: Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin [Phase 3]
Phase 3 trial update comparing Tavocept to placebo in combination therapy for newly diagnosed or relapsed advanced non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2022-07-13Clinical Trial Update: Real-world Therapy of ALK-positive NSCLC in Sweden: the Sequencing of ALK Tyrosine Kinase Inhibitor Drugs and Their Therapeutic Outcomes Based on Data From National Registers.
A completed real-world study from Sweden examining sequencing of ALK tyrosine kinase inhibitors and therapeutic outcomes in ALK-positive non…
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab and erlotinib in advanced non-small cell lung cancer has completed with results posted.